Treatment of patients with refractory diffuse large B-cell lymphoma or mantle cell lymphoma with alemtuzumab, alone or in combination with cytotoxic chemotherapy

被引：3
作者：
Yi, Jun Ho [1 ]
Kim, Seok Jin [1 ]
Ko, Young Hyeh [2 ]
Kim, Won Seog [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Div Hematol Oncol, Dept Med,Samsung Med Ctr, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul 135710, South Korea
来源：
LEUKEMIA & LYMPHOMA | 2011年 / 52卷 / 02期
关键词：
PLUS RITUXIMAB; ELDERLY-PATIENTS; PHASE-II; CHOP; EXPRESSION; RESISTANCE; NEOPLASMS; CD52;
D O I：
10.3109/10428194.2010.529203
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：317 / 320
页数：4
相关论文
共 15 条
[1]   Alemtuzumab in the treatment of chronic lymphocytic lymphoma [J].
Boyd, Kevin ;
Dearden, Claire E. .
EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (04) :525-533
[2]   Revised response criteria for malignant lymphoma [J].
Cheson, Bruce D. ;
Pfistner, Beate ;
Juweid, Malik E. ;
Gascoyne, Randy D. ;
Specht, Lena ;
Horning, Sandra J. ;
Coiffier, Bertrand ;
Fisher, Richard I. ;
Hagenbeek, Anton ;
Zucca, Emanuele ;
Rosen, Steven T. ;
Stroobants, Sigrid ;
Lister, T. Andrew ;
Hoppe, Richard T. ;
Dreyling, Martin ;
Tobinai, Kensei ;
Vose, Julie M. ;
Connors, Joseph M. ;
Federico, Massimo ;
Diehl, Volker .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :579-586
[3]   CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. [J].
Coiffier, B ;
Lepage, E ;
Brière, J ;
Herbrecht, R ;
Tilly, H ;
Bouabdallah, R ;
Morel, P ;
Van den Neste, E ;
Salles, G ;
Gaulard, P ;
Reyes, F ;
Gisselbrecht, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) :235-242
[4]   CD52 over-expression affects rituximab-associated complement-mediated cytotoxicity but not antibody-dependent cellular cytotoxicity: Preclinical evidence that targeting CD52 with alemtuzumab may reverse acquired resistance to rituximab in non-Hodgkin lymphoma [J].
Cruz, Raymond I. ;
Hernandez-Ilizaliturri, Francisco J. ;
Olejniczak, Scott ;
Deeb, George ;
Knight, Joy ;
Wallace, Paul ;
Thurberg, Beth L. ;
Kennedy, William ;
Czuczman, Myron S. .
LEUKEMIA & LYMPHOMA, 2007, 48 (12) :2424-2436
[5]   A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas [J].
Enblad, G ;
Hagberg, H ;
Erlanson, M ;
Lundin, J ;
MacDonald, AP ;
Repp, R ;
Schetelig, J ;
Seipelt, G ;
Österborg, A .
BLOOD, 2004, 103 (08) :2920-2924
[6]   Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma:: A study by the groupe d'Etude des lymphomes de l'adulte [J].
Feugier, P ;
Van Hoof, A ;
Sebban, C ;
Solal-Celigny, P ;
Bouabdallah, R ;
Fermé, C ;
Christian, B ;
Lepage, E ;
Tilly, H ;
Morschhauser, F ;
Gaulard, P ;
Salles, G ;
Bosly, A ;
Gisselbrecht, C ;
Reyes, F ;
Coiffier, B .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) :4117-4126
[7]   Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study [J].
Kim, Jong Gwang ;
Sohn, Sang Kyun ;
Chae, Yee Soo ;
Cho, Yoon Young ;
Yang, Deok Hwan ;
Lee, Je-Jung ;
Kim, Hyeoung-Joon ;
Shin, Ho Jin ;
Chung, Joo Seop ;
Cho, Goon Jae ;
Lee, Won-Sik ;
Joo, Young-Don ;
Sohn, Chang-Hak ;
Oh, Suk Joong .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (01) :129-134
[8]   Alemtuzumab and DHAP (A-DHAP) is effective for relapsed peripheral T-cell lymphoma, unspecified: interim results of a phase II prospective study [J].
Kim, S. J. ;
Kim, K. ;
Kim, B. S. ;
Suh, C. ;
Huh, J. ;
Ko, Y. H. ;
Kim, W. S. .
ANNALS OF ONCOLOGY, 2009, 20 (02) :390-392
[9]   CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma [J].
Marcus, R ;
Imrie, K ;
Belch, A ;
Cunningham, D ;
Flores, E ;
Catalano, J ;
Solal-Celigny, P ;
Offner, F ;
Walewski, J ;
Raposo, J ;
Jack, A ;
Smith, P .
BLOOD, 2005, 105 (04) :1417-1423
[10]   Immunophenotypic identification of possible therapeutic targets in paediatric non-Hodgkin lymphomas: a children's oncology group report [J].
Miles, Rodney R. ;
Cairo, Mitchell S. ;
Satwani, Prakash ;
Zwick, David L. ;
Lones, Mark A. ;
Sposto, Richard ;
Abromovitch, Minnie ;
Tripp, Sheryl ;
Angiolillo, Anne L. ;
Roman, Elizabeth ;
Davenport, Virginia ;
Perkins, Sherrie L. .
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 138 (04) :506-512
12